Consensus Statements

• Baseline Cardiac Assessment in Individuals Receiving Immune Checkpoint Inhibitors - A Joint Consensus Statement V1.0

This ground-breaking statement provides critical guidance on cardiac evaluations for patients receiving immune checkpoint inhibitors (ICIs), ensuring optimal care and minimising risks associated with cardiotoxicities. This statement has been authored in collaboration with the British Cardio-Oncology Society (BCOS).